Maria de Nazaret D. V.
- Country
- Spain
- Department
- #9109 Hemodinamica y Hematologia
Research Overview
Data & Insights
Has run more than one trial at 0 of 69 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating follicular lymphoma, with particular focus on managing cases that have become resistant to initial treatments or have relapsed. Their research interests encompass innovative therapeutic approaches for refractory hematological malignancies.
- Lymphoma Treatment
- Novel Combination Therapies
- Treatment-Resistant Lymphomas
Their expertise extends to developing treatment strategies for patients who require advanced therapeutic interventions.
Targeted Therapies
The investigator focuses on evaluating targeted therapeutic approaches in blood cancers, particularly exploring the role of epigenetic modifiers in lymphoma treatment. Their work involves assessing combination treatments that include both established and emerging therapies.
- Epigenetic Therapy
- Immunomodulatory Treatments
- Rituximab-Based Regimens
Their research encompasses evaluation of novel drug combinations to enhance treatment outcomes.
Clinical Assessment
The investigator specializes in conducting comprehensive evaluations of treatment efficacy and safety profiles in lymphoma therapies. Their expertise includes assessment of pharmacodynamic and pharmacokinetic parameters in novel treatment combinations.
- Treatment Safety Assessment
- Drug Response Monitoring
- Clinical Outcomes Analysis
Their work involves detailed monitoring of patient responses to innovative treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.